Omnicell Management
Management criteria checks 2/4
Omnicell's CEO is Randy Lipps, appointed in Sep 1992, has a tenure of 32.33 years. total yearly compensation is $11.02M, comprised of 7.4% salary and 92.6% bonuses, including company stock and options. directly owns 1.13% of the company’s shares, worth $23.30M. The average tenure of the management team and the board of directors is 3 years and 4.6 years respectively.
Key information
Randy Lipps
Chief executive officer
US$11.0m
Total compensation
CEO salary percentage | 7.4% |
CEO tenure | 32.3yrs |
CEO ownership | 1.1% |
Management average tenure | 3yrs |
Board average tenure | 4.6yrs |
Recent management updates
Recent updates
Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues
Nov 27Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next
Nov 02Omnicell Q3 Earnings: Look At The Growth Segment
Nov 01Is It Time To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Oct 31Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?
Oct 07Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%
Aug 02Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?
Jul 11Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Jun 16Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt
May 25An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued
Mar 28Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues
Feb 29Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Feb 23Omnicell Is Building A Strong Moat
Feb 22Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?
Jan 15Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Dec 25Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?
Dec 06Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%
Nov 10Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?
Sep 06Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?
Aug 08Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching
Jul 02A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)
Jun 08Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital
Apr 29Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?
Apr 11At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?
Mar 23Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?
Feb 28Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)
Jan 15We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt
Jan 01Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?
Nov 17Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers
Nov 03Omnicell launches Specialty Pharmacy Services
Oct 11Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly
Sep 30Omnicell says advance services to drive profitable growth in long-run: Investor Day
Sep 20Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?
Sep 15Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger
Aug 31Omnicell reports Q2 earnings miss; reaffirms FY22 guidance and issues Q3 outlook
Aug 04Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?
Aug 03CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$18m |
Jun 30 2024 | n/a | n/a | -US$21m |
Mar 31 2024 | n/a | n/a | -US$21m |
Dec 31 2023 | US$11m | US$813k | -US$20m |
Sep 30 2023 | n/a | n/a | -US$34m |
Jun 30 2023 | n/a | n/a | -US$23m |
Mar 31 2023 | n/a | n/a | -US$18m |
Dec 31 2022 | US$8m | US$804k | US$6m |
Sep 30 2022 | n/a | n/a | US$48m |
Jun 30 2022 | n/a | n/a | US$61m |
Mar 31 2022 | n/a | n/a | US$72m |
Dec 31 2021 | US$8m | US$768k | US$78m |
Sep 30 2021 | n/a | n/a | US$80m |
Jun 30 2021 | n/a | n/a | US$60m |
Mar 31 2021 | n/a | n/a | US$35m |
Dec 31 2020 | US$8m | US$721k | US$32m |
Sep 30 2020 | n/a | n/a | US$38m |
Jun 30 2020 | n/a | n/a | US$49m |
Mar 31 2020 | n/a | n/a | US$69m |
Dec 31 2019 | US$7m | US$711k | US$61m |
Sep 30 2019 | n/a | n/a | US$54m |
Jun 30 2019 | n/a | n/a | US$48m |
Mar 31 2019 | n/a | n/a | US$38m |
Dec 31 2018 | US$6m | US$690k | US$38m |
Compensation vs Market: Randy's total compensation ($USD11.02M) is above average for companies of similar size in the US market ($USD5.43M).
Compensation vs Earnings: Randy's compensation has increased whilst the company is unprofitable.
CEO
Randy Lipps (67 yo)
32.3yrs
Tenure
US$11,022,072
Compensation
Mr. Randall A. Lipps, also known as Randy, founded Omnicell, Inc. in September 1992 and has been its Chief Executive Officer and President since October 2002. Mr. Lipps had been Executive Chairman and Exec...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 32.3yrs | US$11.02m | 1.13% $ 23.3m | |
Executive VP & CFO | 1.6yrs | US$5.16m | 0.024% $ 487.1k | |
Executive VP | 3.5yrs | US$3.06m | 0.020% $ 402.7k | |
Executive VP & COO | less than a year | no data | no data | |
VP, Chief Accounting Officer & Corporate Controller | less than a year | no data | no data | |
Senior VP & Chief Information Officer | 5.3yrs | no data | no data | |
Senior Vice President of Investor Relations | no data | no data | no data | |
Senior VP & Chief People Officer | 1.6yrs | no data | no data | |
Senior Vice President of Global Operations | less than a year | no data | no data | |
Senior VP & GM of International | 3yrs | no data | no data | |
Senior Vice President of Quality & Product Regulatory | 3yrs | no data | no data | |
Chief of Staff | 7.5yrs | no data | no data |
3.0yrs
Average Tenure
50yo
Average Age
Experienced Management: OMCL's management team is considered experienced (3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 32.3yrs | US$11.02m | 1.13% $ 23.3m | |
Independent Director | less than a year | no data | 0.018% $ 377.8k | |
Independent Director | 12yrs | US$328.81k | 0.13% $ 2.6m | |
Director Emeritus | less than a year | US$286.45k | no data | |
Independent Director | 5.8yrs | US$322.67k | 0.087% $ 1.8m | |
Lead Independent Director | 11yrs | US$341.69k | 0.082% $ 1.7m | |
Independent Director | 3.5yrs | US$301.80k | 0.025% $ 512.0k | |
Independent Director | 5.7yrs | US$297.77k | 0.035% $ 717.2k | |
Independent Director | 2.7yrs | US$279.13k | 0.022% $ 449.3k | |
Independent Director | 1.5yrs | US$173.92k | 0.018% $ 361.5k |
4.6yrs
Average Tenure
67yo
Average Age
Experienced Board: OMCL's board of directors are considered experienced (4.6 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/02 04:00 |
End of Day Share Price | 2025/01/02 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Omnicell, Inc. is covered by 26 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
K. Juhng | BB&T Capital Markets |
William Sutherland | Benchmark Company |
Raymond Myers | Benchmark Company |